Perception Neuroscience Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Perception Neuroscience General Information

Description

Developer of arketamine therapy intended to provide effective treatment solutions to serious psychiatric disorders.The company's lead product is the NMDA antagonist arketamine with the potential for rapid acting antidepressant activity and anti-suicidal effects.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • New York, NY
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Corporate Office
  • New York, NY
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Perception Neuroscience Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Perception Neuroscience‘s full profile, request access.

Request a free trial

Perception Neuroscience Patents

Perception Neuroscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3110736-A1 Device and method for providing assistance information to a visually impaired or blind user Active 21-May-2020
FR-3110736-B1 Device and method for providing assistance information to a visually impaired or blind user Active 21-May-2020
US-20160335597-A1 Server for providing information for group decision and method thereof Inactive 12-May-2015
US-10318577-B2 Method for identifying user's needs based on image word interpretation Active 06-Jan-2015
US-20160196285-A1 Method for identifying user's needs based on image word interpretation Active 06-Jan-2015 G06F16/5866
To view Perception Neuroscience’s complete patent history, request access »

Perception Neuroscience FAQs

  • When was Perception Neuroscience founded?

    Perception Neuroscience was founded in 2018.

  • Where is Perception Neuroscience headquartered?

    Perception Neuroscience is headquartered in New York, NY.

  • What industry is Perception Neuroscience in?

    Perception Neuroscience’s primary industry is Drug Discovery.

  • Is Perception Neuroscience a private or public company?

    Perception Neuroscience is a Private company.

  • What is Perception Neuroscience’s current revenue?

    The current revenue for Perception Neuroscience is .

  • When was Perception Neuroscience acquired?

    Perception Neuroscience was acquired on 03-Jan-2019.

  • Who acquired Perception Neuroscience?

    Perception Neuroscience was acquired by AtaiBeckley.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process